【Biotech Investment News】Sanofi’s Strategic Deals in 2025: A Comprehensive Summary
Key Pharma Moves: Sanofi’s Acquisitions and Collaborations in Q1–Q3 2025 In 2025, Sanofi has executed several key strategic acquisitions and licensing deals focused on immunology, neurology, and rare diseases. Here's a summary of these d...